دورية أكاديمية
أعرض في EDS

Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?

التفاصيل البيبلوغرافية
العنوان: Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?
المؤلفون: Zorzella-Pezavento SFG; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Mimura LAN; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Denadai MB; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., de Souza WDF; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Fraga-Silva TFC; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Sartori A; Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
المصدر: Neural regeneration research [Neural Regen Res] 2022 Sep; Vol. 17 (9), pp. 1945-1954.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Medknow Country of Publication: India NLM ID: 101316351 Publication Model: Print Cited Medium: Print ISSN: 1673-5374 (Print) Linking ISSN: 16735374 NLM ISO Abbreviation: Neural Regen Res Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2013 - : Mumbai : Wolters Kluwer Health, Medknow
Original Publication: Shenyang : Editorial Board of Neural Regeneration Research
مستخلص: Multiple sclerosis is an autoimmune treatable but not curable disease. There are a multiplicity of medications for multiple sclerosis therapy, including a class entitled disease-modifying drugs that are mainly indicated to reduce the number and severity of disease relapses. Not all patients respond well to these therapies, and minor to severe adverse effects have been reported. Vitamin D, called sunshine vitamin, is being studied as a possible light at the end of the tunnel. In this review, we recapitulated the similar immunopathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis, the immunomodulatory and neuroprotective potential of vitamin D and the state-of-art concerning its supplementation to multiple sclerosis patients. Finally, based on our and other groups' experimental findings, we analyzed the need to consider the relevance of the route and the different time-point administration aspects for a more rational indication of this vitamin to multiple sclerosis patients.
Competing Interests: None
References: Mult Scler. 2014 Feb;20(2):147-55. (PMID: 23836877)
Front Neurol. 2020 Feb 25;11:129. (PMID: 32158426)
J Neuroimmunol. 2015 Sep 15;286:48-58. (PMID: 26298324)
Curr Drug Targets. 2021;22(14):1585-1595. (PMID: 33390128)
CNS Neurosci Ther. 2013 Apr;19(4):269-77. (PMID: 23521914)
Immunology. 2020 Aug;160(4):325-335. (PMID: 32249925)
Nat Rev Immunol. 2008 Jul;8(7):523-32. (PMID: 18566595)
Mult Scler Relat Disord. 2017 May;14:35-45. (PMID: 28619429)
Clin Exp Immunol. 2010 Oct;162(1):1-11. (PMID: 20682002)
Nature. 2012 Aug 30;488(7413):595-6. (PMID: 22932379)
Acta Neurol Belg. 2018 Sep;118(3):361-377. (PMID: 30006858)
Acta Neurol Scand. 2019 Feb;139(2):172-176. (PMID: 30317548)
Acta Neuropathol Commun. 2014 Dec 05;2:163. (PMID: 25476447)
Eur J Clin Nutr. 2016 Sep;70(9):995-9. (PMID: 27026420)
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):. (PMID: 29311129)
Eur J Neurol. 2012 Jul;19(7):955-62. (PMID: 22289117)
J Neuroimmunol. 2013 Oct 15;263(1-2):64-74. (PMID: 23968560)
Immunity. 2009 Oct 16;31(4):677-89. (PMID: 19833089)
CNS Neurosci Ther. 2015 Mar;21(3):222-30. (PMID: 25403984)
Mycoses. 2016 Nov;59(11):697-704. (PMID: 27061227)
Nat Rev Neurol. 2017 Jan;13(1):25-36. (PMID: 27934854)
Autoimmunity. 2011 May;44(3):219-28. (PMID: 20883149)
Immunol Today. 1998 Apr;19(4):163-8. (PMID: 9577092)
Neurology. 2012 Nov 20;79(21):2140-5. (PMID: 23170011)
J Neuroinflammation. 2011 May 24;8:56. (PMID: 21605467)
Front Immunol. 2018 Mar 21;9:514. (PMID: 29619025)
Nat Rev Immunol. 2017 Sep;17(9):535-544. (PMID: 28555673)
J Neuroimmunol. 2003 Jan;134(1-2):128-32. (PMID: 12507780)
Mol Immunol. 2019 Jan;105:198-204. (PMID: 30550982)
J Neuroinflammation. 2019 Mar 1;16(1):53. (PMID: 30823925)
Mol Neurobiol. 2018 Aug;55(8):6463-6479. (PMID: 29318446)
Acta Neuropathol. 2017 Feb;133(2):223-244. (PMID: 27766432)
Neuroscience. 2016 Mar 11;317:130-40. (PMID: 26762804)
J Neuroimmunol. 2019 May 15;330:67-73. (PMID: 30831520)
Indian J Clin Biochem. 2013 Jul;28(3):255-8. (PMID: 24426220)
Vitam Horm. 2011;86:401-28. (PMID: 21419282)
J Neuroimmunol. 2018 Jan 15;314:50-57. (PMID: 29153546)
Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4004-11. (PMID: 26592821)
Lancet Neurol. 2017 Jun;16(6):413-414. (PMID: 28504102)
Acta Neurol Scand. 2020 Jan;141(1):77-80. (PMID: 31657006)
Mult Scler. 2003 Dec;9(6):540-9. (PMID: 14664465)
Ann Neurol. 2018 Jun;83(6):1147-1161. (PMID: 29679417)
Neurology. 2012 Jul 17;79(3):267-73. (PMID: 22700809)
Annu Rev Nutr. 2014;34:117-41. (PMID: 25033060)
Sci Adv. 2017 Jul 12;3(7):e1700492. (PMID: 28706993)
J Autoimmun. 2018 Jan 21;:. (PMID: 29395738)
Nat Med. 2002 May;8(5):500-8. (PMID: 11984595)
Arch Biochem Biophys. 2002 Dec 15;408(2):200-4. (PMID: 12464272)
J Autoimmun. 2017 May;79:39-52. (PMID: 28126203)
Neurology. 2018 Apr 3;90(14):e1191-e1199. (PMID: 29514944)
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4615-22. (PMID: 20660719)
Dermatoendocrinol. 2011 Oct;3(4):220-9. (PMID: 22259647)
PLoS One. 2015 May 12;10(5):e0125836. (PMID: 25965341)
Neurotherapeutics. 2020 Jan;17(1):218-234. (PMID: 31463682)
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S265-77. (PMID: 19545951)
J Neuroimmunol. 2016 Nov 15;300:47-56. (PMID: 27806875)
J Neurochem. 1985 Apr;44(4):1138-41. (PMID: 3838342)
Nat Med. 2007 Oct;13(10):1173-5. (PMID: 17828272)
Iran J Pathol. 2018 Winter;13(1):10-22. (PMID: 29731791)
J Immunol. 2005 Sep 1;175(5):3025-32. (PMID: 16116190)
Nature. 2019 Aug;572(7770):481-487. (PMID: 31391585)
CNS Neurosci Ther. 2016 Oct;22(10):807-16. (PMID: 27321391)
Handb Clin Neurol. 2014;122:173-89. (PMID: 24507518)
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861-4. (PMID: 8755567)
Free Radic Biol Med. 2020 Dec;161:139-149. (PMID: 33068737)
J Neurochem. 2016 Jan;136 Suppl 1:29-38. (PMID: 26119245)
Eur J Immunol. 2000 Feb;30(2):498-508. (PMID: 10671205)
Mediators Inflamm. 2016;2016:5314541. (PMID: 26941483)
Mult Scler Relat Disord. 2020 May;40:101921. (PMID: 31951862)
PLoS One. 2015 Dec 17;10(12):e0144084. (PMID: 26679341)
J Clin Invest. 1991 Mar;87(3):1103-7. (PMID: 1705564)
Neural Regen Res. 2020 Nov;15(11):1995-2007. (PMID: 32394947)
Int J Mol Sci. 2021 Feb 15;22(4):. (PMID: 33671896)
Mult Scler. 2021 May;27(6):807-811. (PMID: 32507072)
Nutrients. 2018 Jul 24;10(8):. (PMID: 30042334)
Front Immunol. 2016 Dec 23;7:627. (PMID: 28066436)
J Immunol. 2009 Nov 1;183(9):5458-67. (PMID: 19843932)
J Parkinsons Dis. 2016;6(1):29-37. (PMID: 26756741)
Front Physiol. 2016 Nov 15;7:498. (PMID: 27895587)
Brain Behav. 2016 Dec 07;7(2):e00609. (PMID: 28239520)
Immunology. 2017 Nov;152(3):414-424. (PMID: 28617989)
J Neuroimmunol. 2020 Jan 15;338:577105. (PMID: 31731231)
J Neuroimmunol. 2000 Mar 1;103(2):171-9. (PMID: 10696912)
J Immunol. 2017 Jan 15;198(2):681-690. (PMID: 27986906)
J Steroid Biochem Mol Biol. 2018 Mar;177:129-134. (PMID: 28893622)
Immunology. 2019 Jan;156(1):9-22. (PMID: 30222193)
Front Neuroendocrinol. 2013 Jan;34(1):47-64. (PMID: 22796576)
Brain Pathol. 2001 Jan;11(1):92-106. (PMID: 11145206)
Front Immunol. 2017 Oct 16;8:1198. (PMID: 29085356)
PLoS One. 2010 Sep 23;5(9):e12925. (PMID: 20886077)
Eur J Neurol. 2015 Mar;22(3):564-9. (PMID: 25530281)
Mult Scler J Exp Transl Clin. 2020 Jan 24;6(1):2055217320903474. (PMID: 32047645)
Cell. 2008 May 30;133(5):775-87. (PMID: 18510923)
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):316-21. (PMID: 17368179)
Iran J Immunol. 2015 Mar;12(1):35-49. (PMID: 25784096)
Brain Sci. 2020 Sep 22;10(9):. (PMID: 32972010)
Nutrients. 2015 Sep 24;7(10):8251-60. (PMID: 26404359)
Neurosciences (Riyadh). 2015 Oct;20(4):329-35. (PMID: 26492110)
Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1139-45. (PMID: 20556470)
Front Immunol. 2013 Jun 18;4:148. (PMID: 23785369)
Antioxid Redox Signal. 2011 Apr 1;14(7):1275-88. (PMID: 20615073)
J Immunol. 2010 Nov 15;185(10):5953-61. (PMID: 20944000)
Front Neurol. 2016 Dec 08;7:218. (PMID: 28008324)
Clin Rev Allergy Immunol. 2017 Jun;52(3):436-445. (PMID: 28025778)
Mult Scler Relat Disord. 2018 Jul;23:56-61. (PMID: 29778041)
PLoS Genet. 2019 Jan 17;15(1):e1007808. (PMID: 30653506)
Clin Rev Allergy Immunol. 2012 Feb;42(1):102-11. (PMID: 22095454)
Biomed Res Int. 2018 May 22;2018:9276380. (PMID: 29951549)
JAMA Neurol. 2015 Dec;72(12):1458-65. (PMID: 26458124)
Iran J Neurol. 2015 Jan 5;14(1):17-21. (PMID: 25874052)
J Neurosci Res. 2017 Oct;95(10):1973-1983. (PMID: 28084640)
Acta Neuropathol. 2019 Sep;138(3):443-456. (PMID: 31030237)
Mult Scler. 2017 Apr;23(5):628-636. (PMID: 27956557)
Int Immunol. 2015 May;27(5):237-44. (PMID: 25574039)
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6800-5. (PMID: 11371626)
J Immunol. 1998 Jun 1;160(11):5314-9. (PMID: 9605130)
J Autoimmun. 2017 Dec;85:78-97. (PMID: 28733125)
Neurology. 2016 Jan 26;86(4):382-90. (PMID: 26718578)
Nature. 2012 Aug 30;488(7413):675-9. (PMID: 22914092)
Acta Clin Croat. 2018 Jun;57(2):352-361. (PMID: 30431730)
Consult Pharm. 2017 Jun 1;32(6):337-339. (PMID: 28595683)
Ann Neurol. 2018 Jun;83(6):1162-1173. (PMID: 29740872)
BMJ. 2003 Aug 9;327(7410):316. (PMID: 12907484)
Front Pharmacol. 2020 Mar 12;11:161. (PMID: 32226379)
J Neurosci Res. 2018 Jun;96(6):1021-1042. (PMID: 29446144)
Neurology. 2020 May 5;94(18):e1950-e1960. (PMID: 32300060)
PLoS One. 2011;6(11):e27473. (PMID: 22110656)
J Biol Chem. 2015 May 8;290(19):12222-36. (PMID: 25809484)
Cochrane Database Syst Rev. 2010 Dec 08;(12):CD008422. (PMID: 21154396)
J Neuroinflammation. 2017 Jun 9;14(1):117. (PMID: 28599652)
J Clin Invest. 2004 Apr;113(7):990-7. (PMID: 15057305)
J Immunol. 2006 Nov 1;177(9):6030-7. (PMID: 17056528)
Nat Genet. 2015 Oct;47(10):1107-1113. (PMID: 26343388)
Expert Rev Clin Immunol. 2016 Oct;12(10):1069-89. (PMID: 27191526)
Brain Behav. 2020 Jan;10(1):e01498. (PMID: 31837111)
J Immunol. 2009 Feb 15;182(4):2074-83. (PMID: 19201860)
FASEB J. 2010 Apr;24(4):1023-34. (PMID: 19940258)
Neurol Ther. 2018 Jun;7(1):59-85. (PMID: 29243029)
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1678-E1687. (PMID: 28196884)
J Steroid Biochem Mol Biol. 2016 Apr;158:178-188. (PMID: 26704532)
Eur Neurol. 2018;80(1-2):93-99. (PMID: 30343306)
Nutr Neurosci. 2019 Oct;22(10):725-737. (PMID: 29447086)
Mult Scler. 2012 Aug;18(8):1144-51. (PMID: 22354743)
Anat Cell Biol. 2012 Sep;45(3):141-8. (PMID: 23094201)
Mult Scler. 2019 Jul;25(8):1162-1169. (PMID: 29932357)
J Allergy Clin Immunol. 2011 Jun;127(6):1532-40.e7. (PMID: 21497886)
Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21101-6. (PMID: 24324134)
J Neurosci Res. 2006 May 15;83(7):1299-309. (PMID: 16547967)
Exp Mol Med. 2018 Apr 16;50(4):1-14. (PMID: 29657326)
BMC Neurol. 2019 Nov 13;19(1):284. (PMID: 31722673)
J Immunol. 2020 Jan 15;204(2):316-326. (PMID: 31907274)
Science. 2019 Sep 27;365(6460):. (PMID: 31604244)
Mult Scler. 2021 Apr;27(4):494-502. (PMID: 32406797)
JAMA. 2006 Dec 20;296(23):2832-8. (PMID: 17179460)
PLoS One. 2015 Mar 27;10(3):e0122821. (PMID: 25815722)
Curr Opin Neurol. 2015 Jun;28(3):206-19. (PMID: 25887768)
Brain Pathol. 2007 Apr;17(2):210-8. (PMID: 17388952)
J Neurol. 2018 Feb;265(2):348-355. (PMID: 29243005)
PLoS One. 2013;8(3):e58808. (PMID: 23516559)
J Physiol. 2017 Nov 15;595(22):6825-6836. (PMID: 28949008)
Neurology. 2019 Nov 12;93(20):e1906-e1916. (PMID: 31594857)
Mediators Inflamm. 2018 Apr 17;2018:1549549. (PMID: 29849483)
Iran J Neurol. 2015 Apr 4;14(2):67-73. (PMID: 26056550)
Front Immunol. 2015 Nov 09;6:569. (PMID: 26617604)
J Mol Endocrinol. 2000 Oct;25(2):141-8. (PMID: 11013342)
Cell Host Microbe. 2009 Sep 17;6(3):201-3. (PMID: 19748462)
Eur J Immunol. 2020 Nov;50(11):1626-1642. (PMID: 33067808)
Nat Rev Drug Discov. 2010 Dec;9(12):941-55. (PMID: 21119732)
Mult Scler. 2014 Jul;20(8):1042-9. (PMID: 24414538)
J Adv Res. 2015 Nov;6(6):793-804. (PMID: 26644915)
Biochim Biophys Acta. 2011 Feb;1812(2):252-64. (PMID: 20619340)
J Neuroimmunol. 2015 Mar 15;280:1-7. (PMID: 25773147)
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 6;6(5):. (PMID: 31454777)
Toxins (Basel). 2015 Nov 13;7(11):4730-44. (PMID: 26580651)
Exp Mol Pathol. 2017 Jun;102(3):515-521. (PMID: 28552332)
Chem Biol. 2014 Mar 20;21(3):319-29. (PMID: 24529992)
J Neuroimmunol. 2015 Mar 15;280:21-8. (PMID: 25773151)
Mult Scler. 2019 Aug;25(9):1326-1328. (PMID: 30358476)
Cell. 2009 Oct 30;139(3):485-98. (PMID: 19836068)
Curr Allergy Asthma Rep. 2011 Feb;11(1):29-36. (PMID: 21104171)
Pharmacol Rep. 2013;65(2):271-8. (PMID: 23744412)
Br J Clin Pharmacol. 2018 Jun;84(6):1121-1127. (PMID: 29498758)
Am J Clin Nutr. 2008 Aug;88(2):582S-586S. (PMID: 18689406)
Am J Transl Res. 2018 Aug 15;10(8):2737-2746. (PMID: 30210711)
Nutrients. 2018 Feb 27;10(3):. (PMID: 29495467)
فهرسة مساهمة: Keywords: central nervous system; cytokines; experimental autoimmune encephalomyelitis; immunomodulation; immunopathogenesis; inflammation; multiple sclerosis; neuroprotection; regulatory T cells; vitamin D
تواريخ الأحداث: Date Created: 20220210 Latest Revision: 20220309
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8848597
DOI: 10.4103/1673-5374.335139
PMID: 35142671
قاعدة البيانات: MEDLINE
الوصف
تدمد:1673-5374
DOI:10.4103/1673-5374.335139